Robeco Institutional Asset Management B.V. Has $25.21 Million Position in Humana Inc. $HUM

Key Points

• Robeco Institutional Asset Management cut its stake in Humana by 54.7% in Q4, selling 118,759 shares and finishing the quarter with 98,411 shares worth about $25.21 million (≈0.08% ownership).
• Insider buying: Sanjay K. Shetty purchased 810 shares at $185.21 on Feb 23, increasing his holding to 11,657 shares (a 7.47% increase), indicating insider conviction amid institutional trimming.
• Analyst sentiment is cautious with several firms lowering targets and a consensus "Hold" rating (average target $224.65), although Humana recently beat quarterly EPS estimates, saw revenue rise 11.3% year‑over‑year, and announced a $0.885 quarterly dividend.

Robeco Institutional Asset Management B.V. reduced its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 54.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 98,411 shares of the insurance provider's stock after selling 118,759 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.08% of Humana worth $25,206,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. CoreCap Advisors LLC boosted its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Rosenberg Matthew Hamilton increased its stake in shares of Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider's stock worth $30,000 after purchasing an additional 68 shares during the period. Mather Group LLC. bought a new position in shares of Humana during the third quarter worth approximately $34,000. Private Wealth Management Group LLC increased its stake in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider's stock worth $39,000 after purchasing an additional 48 shares during the period. Finally, Larson Financial Group LLC increased its stake in shares of Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider's stock worth $40,000 after purchasing an additional 81 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Sanjay K. Shetty acquired 810 shares of the firm's stock in a transaction on Monday, February 23rd. The stock was purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the acquisition, the insider owned 11,657 shares of the company's stock, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.20% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on HUM. Leerink Partners lowered their target price on Humana from $267.00 to $185.00 and set a "market perform" rating on the stock in a research note on Thursday, February 12th. Cantor Fitzgerald lowered their price objective on Humana from $290.00 to $201.00 and set a "neutral" rating on the stock in a research note on Thursday, February 12th. Morgan Stanley set a $146.00 target price on Humana in a report on Thursday, February 12th. TD Cowen reduced their target price on Humana from $260.00 to $173.00 and set a "hold" rating on the stock in a report on Friday, February 13th. Finally, Oppenheimer set a $250.00 target price on Humana in a report on Thursday, February 12th. Seven equities research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $224.65.

Humana Stock Up 3.1%

Shares of NYSE:HUM opened at $198.18 on Tuesday. The firm has a market cap of $23.79 billion, a P/E ratio of 20.18, a P/E/G ratio of 2.06 and a beta of 0.44. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The business has a fifty day simple moving average of $180.77 and a 200 day simple moving average of $232.18. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $315.35.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.01) by $0.05. The company had revenue of $32.64 billion for the quarter, compared to the consensus estimate of $32.08 billion. Humana had a return on equity of 11.43% and a net margin of 0.92%.The firm's revenue was up 11.3% compared to the same quarter last year. During the same period in the previous year, the business earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Friday, March 27th. Humana's payout ratio is currently 36.05%.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.